US Patent 7943730 Genes and polypeptides relating to human pancreatic cancers
Patent 7943730 was granted and assigned to OncoTherapy Science, Inc. on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+372 characters)
Article
Patent abstract
The present application provides novel human genes C1958V1 or C1958V2 whose expression is markedly elevated in pancreatic cancers compared to corresponding non-cancerous tissues. The genes and polypeptides encoded by the genes can be used, for example, in the diagnosis of pancreatic cancer, and as target molecules for developing drugs against the disease.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943730 Genes and polypeptides relating to human pancreatic cancers US Patent 7943730 Genes and polypeptides relating to human pancreatic cancers
Infobox
Patent Number
0794373000
Patent Number
794373000
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079437300
Date of Patent
May 17, 2011
0Patent Application Number
125513720
Date Filed
August 31, 2009
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079437300
Date of Patent
May 17, 2011
0Patent Application Number
125513720
Date Filed
August 31, 2009
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943730 Genes and polypeptides relating to human pancreatic cancers
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943730
Date of patent
May 17, 2011
Patent application number
12551372
Date Filed
August 31, 2009
Patent primary examiner
Find more entities like US Patent 7943730 Genes and polypeptides relating to human pancreatic cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
